Those looking to lose weight could soon have some more options, with two new weight-loss drugs set to hit the market.
FOX’s Anna Kooiman has details from New York City:
For the first time in 13 years, the Food & Drug Administration has approved two weight loss drugs, Qsymia and Belviq. Patients meeting specific body mass index requirements and people with ailments like high blood pressure, diabetes and sleep apnea could qualify. The drugs are not covered by most insurance companies.
Critics argue that obese people should simply watch their diet and exercise more, but many physicians believe physical things are happening inside the brain that cause some folks to overeat and gain weight, and that these drugs will help.
Qsymia and Belviq should hit the market this Fall. Side effects for the drugs include headaches, nausea and change in mood, but doctors say they are typically mild cases and can be reversed.
In New York, Anna Kooiman, FOX News Radio.